PARP inhibitors synergize with gemcitabine by potentiating DNA damage in non ‐small‐cell lung cancer

International Journal of Cancer, EarlyView.

Source: International Journal of Cancer - September 24, 2018 Category: Cancer & Oncology Authors: Yu Jiang, Hui Dai, Yang Li, Jun Yin, Shuliang Guo, Shiaw ‐Yih Lin, Daniel J. McGrail Source Type: research